Q3 pharma earnings roundup: AbbVie, Sanofi and Gilead report

AbbVie confirmed the midpoint of its full year adjusted EPS guidance range and declared a dividend increase of 5%.

Related Keywords

Paul Hudson , Lauraj Schumacher , Richarda Gonzalez , Tommy Bracco , , Specialty Care , General Medicines ,